Rho Ventures — 2017 Investments
3 investments dated 2017 · listed companies and verified rows first · show all
Convercent provides support services to clients, working with IT specialists and executive teams to solve enterprise problems.
Enterprise SoftwareDenver, US
Patrick Quinlan(Executive Officer, Director)Chuck Boyle(Executive Officer)Philip Winterburn(Executive Officer)
BoardSteven Foster(Director)R. Douglas Higgins(Director)Cameron Lester(Director)
Board seatHabib Kairouz· per SEC Form D
Co-investorsGolub GrowthRho Capital PartnersSapphire VenturesTola Capital
Cylera provides a healthcare cybersecurity platform focused on connected medical devices, IoT, and IT assets, giving hospitals and health systems visibility, risk assessment, and threat detection across their environments.
CybersecurityHealthtechIoTNew York, US
Timur Ozekcin(Executive Officer, Director)Sean Abraham(Executive Officer, Director)Apostolos Bakoyiannis(Executive Officer)Owen Wilson(Director)
Co-investorsContour Venture PartnersDreamit VenturesEpsilon Health InvestorsFrontier Path VCGreat Oaks Venture CapitalRho Capital Partners+1 more
Takeda is a pharmaceutical company that conducts R&D to develop medicines and vaccines, focusing on core therapeutic areas and treatments for patients with limited or no options.
BiotechDigital HealthHealthtechTokyo, JP
Claudia D'Augusta(Executive Officer)Eduardo Bravo Fernandez de Araoz(Executive Officer, Director)Marie Paule Richard(Executive Officer)Wilfried Dalemans(Executive Officer)
BoardJune Almenoff(Director)Russell Greig(Director)
Co-investorsKleiner PerkinsYsios CapitalKreos Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.